A phase I trial of OBE 022 in healthy volunteers
Phase of Trial: Phase I
Latest Information Update: 01 Mar 2018
At a glance
- Drugs OBE 022 (Primary)
- Indications Preterm labour
- Focus Adverse reactions; First in man; Pharmacokinetics
- 01 Mar 2018 Clinical safety and exposure data will be presented at the 65th Annual Meeting of the Society for Reproductive Investigation (SRI), according to an ObsEva SA media release.
- 11 Sep 2017 According to an ObsEva media release, cardiac safety data from this trial will be presented at the 2017 Annual Meeting of the American College of Clinical Pharmacology (ACCP).
- 13 Jan 2017 Results published in an ObsEva media release.